Impact of Des-Gamma-Carboxy Prothrombin and Tumor Size on the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation
Akinobu Taketomi(Hokkaido University), Y. Maehara(Kyushu University), Tomoharu Yoshizumi(Kyushu University), Kensaku Sanefuji(Kyushu University), Toru Ikegami(Jikei University School of Medicine), K Sugimachi(National Hospital Organization Kyushu Cancer Center), Hideaki Uhciyama(Kyushu University), Hiroto Kayashima(Kyushu University), Yo‐ichi Yamashita(Kumamoto University), Noboru Harada(Kyushu University), Tomohiro Iguchi(Fukuoka Higashi Medical Center), Yuji Soejima(Shinshu University)
Cited by 177
Related Papers
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244